Want to join the conversation?
$ROK 2Q15 10-Q: Sales were $1,550.8MM vs. $1,600.5MM in 2Q14. Cost of sales was $877.6MM vs. $944.7MM in 2Q14. Gross profit was $673.2MM vs. $655.8MM in 2Q14. Net income was $206MM vs. $180.3MM in 2Q14. Diluted earnings per share were $1.51 vs. $1.28 in 2Q14. Operating earnings was $334.2MM vs. $302.1MM in 2Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?